20981 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interferons [IFN] IFN-gamma
2′-branched nucleosides and flaviviridae mutation
#302Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
#303Combination treatment for atopic dermatitis
#304Method for producing autologous proteins
#305Dosing regime and formulations for type B adenovirus
#306Anti-CSPG4 fusions with interferon for the treatment of malignancy
#307CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
#308COMPOSITION AND METHODS OF CULTURE SUPERNATANT OF KHYG-1 CELLS
#309Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer
#310Methods for preserving the viability of retinal ganglion cells in patients with glaucoma by an anti-TNF receptor 2 (anti-TNFR2) antibody
#311Lipid vesicle compositions and methods of use
#312Immunity inducing agent
#313Activators of CXCR3 for the treatment of angiopathies of the eye
#314Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#315Azepane derivatives and methods of treating hepatitis B infections
#316Furin-knockdown bi-functional RNA
#317Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
#318Treatment of bone diseases
#319Method of inducing senescence in tumor cells by administrating TNF-a in combination with IFNa or IFNy
#320Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine
#321Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)
#322Compositions for inducing or suppressing an immune response
#323METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION
#324Combination of local and systemic immunomodulative therapies for melanoma and liver cancer
#325Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#326METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT UNDREGOING TREATMENT WITH A MEK INHIBITOR
#327Method of treating cancer
#328Compositions and methods for preventing cardiac arrhythmia
#329Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
#330Methods of inducing indolamine 2,3—dioxygenase (IDO)
#331IDENTIFYING AND MODULATING MOLECULAR PATHWAYS THAT MEDIATE NERVOUS SYSTEM PLASTICITY
#332Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#333Compositions and methods for preventing cardiac arrhythmia
#334Human Bone-Forming Cells in the Treatment of Conditions and Bone Diseases Associated with Immunodeficiency or Immunosuppression
#335PIRFENIDONE AND ANTI-FIBROTIC THERAPY IN SELECTED PATIENTS
#336Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
#337Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM
#338Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same
#339Embryo implantation
#340COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#341TARGETED VECTORS FOR CANCER IMMUNOTHERAPY
#342NOVEL COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CANCER METASTASIS
#343INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
#344Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#345Biomarkers and combination therapies using oncolytic virus and immunomodulation
#346Sterilized and decellularized extracellular matrix for treating cardiac arrhythmia
#347CD4+ CD25+ T-CELLS ACTIVATED TO A SPECIFIC ANTIGEN
#348Methods for the treatment of hepatitis B and hepatitis D infections
#349Methods for the treatment of hepatitis B and hepatitis D infections
#350Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors
#351Method to modulate pigmentation process in the melanocytes of skin
#352COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS
#353Vaccine immunotherapy for treating cervical cancer in immune suppressed patients
#354Vaccine immunotherapy for treating lymphoma in immune suppressed patients
#355COMPOSITION FOR TARGETING DENDRITIC CELLS
#356METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
#357Methods of administering interferon gamma to absorb fluid from the subretinal space
#358Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
#359Treatments for migraine and related disorders
#360IMMUNOGENIC EPITOPES OF NGEP ANTIGEN
#361Cell secreted proteins for the treatment of myocardial infarction
#362Compositions and methods related to graft versus host disease and treatments thereof
#363Combination Treatments For Hepatitis C
#364Anti-mucin antibodies for early detection and treatment of pancreatic cancer
#365Suppressor of the endogenous interferon-gamma
#366Bioresorbable microparticles
#367Compositions derived from stem cell released molecules and methods for formulation thereof
#368NOVEL BENZIMIDAZOLE DERIVATIVES
#369Activators of CXCR3 for the treatment of angiopathies of the eye
#370Methods and compositions for liquidation of tumors
#371Method for attenuating immune response using mesenchymal stem cells and cytokines
#372Compositions and methods for treatment of intracellular damage and bacterial infection
#373METHODS OF TREATING CANCER AND TESTING MUTATION ZYGOSITY RELATED THERETO
#374Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
#375COMBINATION THERAPY FOR HEPATITIS C VIRUS INFECTION
#376Hepatitis C virus inhibitors
#377IMMUNITY INDUCING AGENT
#378Method of use and preparation of HSA fusion protein composition for skincare
#379Tetrazolones as inhibitors of fatty acid synthase
#380Methods for the treatment of hepatitis B and hepatitis D infections
#381CANCER THERAPY BY EX VIVO ACTIVATED AUTOLOGOUS IMMUNE CELLS
#382GENETIC ADJUVANTS FOR IMMUNOTHERAPY
#383Ex-vivo treatment of T-cells with IFN-λ
#384T-cell redirecting bispecific antibodies for treatment of disease
#385Method for treating malaria
#386Vaccine immunotherapy
#387Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients
#388VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#389Conjugates for the treatment of mesothelioma
#390Oligonucleotide chelate complex—polypeptide compositions and methods
#391COMPOSITION COMPRISING AT LEAST TO COMPOUNDS WHICH INDUCES INDOLAMINE 2,3 - DIOXYGENASE (IDO), FOR THE TREATMENT OF AN AUTOIMMUNE DISORDER OR SUFFERING FROM IMMUNE REJECTION OF ORGANS
#392Hyaluronic acid-protein conjugates and method for preparing same
#393Anticancer fusion protein comprising TRAIL and interferon
#394Vaccine immunotherapy
#395Multi-compartmental macrophage delivery
#396COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
#397Sequential administration of a replication defective adenovirus vector in vaccination protocols
#398Hepatitis C virus inhibitors
#399Methods and compositions for delivering interleukin-1 receptor antagonist
#400SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITIZATION OF TUMOR CELLS
#401Immunobinders directed against sclerostin
#402Methods for treating Friedreich's ataxia with interferon gamma
#403Antibody therapy
#404IN VIVO TARGETING OF DENDRITIC CELLS
#405CO-ADMINISTRATION OF A PARVOVIRUS AND A CYTOKINE FOR THERAPY OF PANCREATIC CANCER
#406MACROPHAGE ACTIVATING FACTOR FOR USE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME (CFS) AND CFS-RELATED DISEASES AND DISORDERS
#407Methods for handling biological drugs containing living cells
#408Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
#4095,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#410Interferon analogs
#411High Pressure Treatment of Aggregated Interferons
#412BOOSTING IMMUNE DEFENSE BY UPREGULATING CCAAT/ENHANCER BINDING PROTEIN EPSILON
#413METHODS AND PRODUCTS RELATED TO METABOLIC INTERACTIONS IN DISEASE
#414Low antigen-dose immunization utilizing overlapping peptides for maximizing T-helper cell 1 (Th1) immunity against a pathogen
#415Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
#416Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#417Treatment for Amyotrophic Lateral Sclerosis
#418Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
#419COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#420COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#421COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#422Method of immunotherapy for treament of human papillomavirus infection
#423Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma
#424Macrocyclic inhibitors of hepatitis C virus replication
#425Treatment for multiple sclerosis
#426Method of treating pulmonary disease with interferons
#427Lipid vesicle compositions and methods of use
#428COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
#429COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION
#430Benzimidazole derivatives
#431Vaccine immunotherapy
#432Ex-vivo treatment of peripheral blood leukocytes with IFN-λ
#433Immunogenic epitopes of NGEP antigen
#434METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#435METHODS AND COMPOSITIONS FOR ISLET CELL PRESERVATION
#436Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin
#437Hepatitis C virus inhibitors
#438Antibody therapy
#439Low antigen-dose immunization for maximizing T-helper cell 1 (Th1) immunity against a pathogen
#440Methods of administering interferon gamma to absorb fluid from the subretinal space
#441Tetrazolones as inhibitors of fatty acid synthase
#442CONJUGATES FOR THE TREATMENT OF MESOTHELIOMA
#443Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine
#444Methods and compositions for inhibition of Treg cells
#445Dihydropyrazolopyrimidinone derivatives
#446Therapeutic agent for hematopoietic tumors
#447Composition for targeting dendritic cells
#448B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#449USE OF PLANT-DERIVED RECOMBINANT GROWTH FACTORS IN SKIN CARE
#450Antibody therapy
#451AMYLOID BETA-PEPTIDES AND METHODS OF USE THEREOF
#452COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
#453Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
#454Furin-knockdown bi-functional RNA
#4555,5-fused arylene or heteroarylene hepatitis C virus inhibitors
#456Methods and compositions for liquidation of tumors
#4572′-branched nucleosides and mutation
#458NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#459NRF2 SCREENING ASSAYS AND RELATED METHODS AND COMPOSITIONS
#460IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#461IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#462HUMAN BONE-FORMING CELLS IN THE TREATMENT OF CONDITIONS AND BONE DISEASES ASSOCIATED WITH IMMUNODEFICIENCY OR IMMUNOSUPPRESSION
#463METHOD TO ENHANCE HEMATOPOIESIS
#464NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#465Materials and methods for prevention and treatment of RNA viral diseases
#466USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE
#467Skincare composition comprising HSA fusion protein, preparation method and uses thereof
#468Therapeutic compounds
#469Compositions and methods for treatment of angiogenesis in pathological lesions
#470AMETHOD OF TREATING NEURODEGENERATIVE DISEASES
#471Hepatitis C virus inhibitors
#472Compositions and methods for preventing cardiac arrhythmia
#473Targeted vectors for cancer immunotherapy
#474Antibody therapy
#475Pathway for Th-17 Cell Development and Methods Utilizing Same
#476Sequential administration of a replication defective adenovirus vector in vaccination protocols
#477Synergism Between Activated Immune Cells and Conventional Cancer Therapies
#478Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#479SUPRA MOLECULAR CONSTRUCT FOR DELIVERY OF INTERFERON TO A MAMMAL
#480Recombinant VSV For The Treatment of Tumor Cells
#481Conjoint therapy for treating fibrotic diseases
#482Methods of organ regeneration using Hox11-expressing pluripotent cells
#483Vaccine immunotherapy
#484COMPOSITIONS AND METHODS FOR PRESERVING CELLS OF THE EYE
#485ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS
#486METHOD TO CONTROL DENGUE VIRUSES IN HUMANS BY PICOLINIC ACID AND DERIVATIVES THEREOF
#487Method of treating pulmonary disease with interferons
#488TREATMENT OF UTERINE CANCER AND OVARIAN CANCER WITH A PARP INHIBITOR ALONE OR IN CONBINATION WITH ANTI-TUMOR AGENTS
#489SUBSTITUTED CYCLIC PYRROLIDINE DERIVATIVES
#490Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions
#491COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION
#492Identifying and modulating molecular pathways that mediate nervous system plasticity
#493CYSTEINE DIOXYGENASE POLYMORPHISMS
#494Genetic adjuvants for immunotherapy
#495Enhanced antiviral activity against foot and mouth disease
#496Macrocyclic inhibitors of hepatitis C virus replication
#497METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#498USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE
#499Eye-drop vaccine containing copolymer 1 for therapeutic immunization
#500High pressure treatment of aggregated interferons
#501Kit containing stem cells and cytokines for use in attenuating immune responses
#502METHOD OF TREATING HEPATITIS VIRUS INFECTION WITH A MULTIPHASIC INTERFERON DELIVERY PROFILE
#503Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
#504NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#505Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
#506NOVEL PHARMACEUTICAL COMPOSITION OF INTERFERON GAMMA OR PIRFENIDONE WITH MOLECULAR DIAGNOSTICS FOR THE IMPROVED TREATMENT OF INTERSTITIAL LUNG DISEASES
#507Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y
#508TREATMENT OF UTERINE CANCER AND OVARIAN CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTI-TUMOR AGENTS
#509INHIBITORS OF SERINE PROTEASE ACTIVITY AND THEIR USE IN METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#510Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing OSMRβ as a subunit, and applications thereof
#511Antibody therapy
#512Bioactive molecular matrix and methods of use in the treatment of disease
#513COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTION AND SARS
#514COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha
#515Novel Pharmaceuticals That Use Anti-HLA Antibodies
#516Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis
#517Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
#518Cd4+ Cd25+ T-cells activated to a specific antigen
#519Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
#520METHOD TO ENHANCE HEMATOPOIESIS
#521Imidazole and Thioazole Derivatives as Antiviral Agents
#522Stabilization of Biologically Active Proteins With Mixtures of Polysaccharides and Amino Acid Based Compounds
#523Cancer-targeted viral vectors
#524HARNESSING WNT SIGNALING TO RESTRICT HIV REPLICATION
#525Methods and products related to metabolic interactions in disease
#526Methods and products related to metabolic interactions in disease
#527Materials and Methods for Prevention and Treatment of RNA Viral Diseases
#528Interleukin-15 antagonists for the treatment of anemia
#529Method and pharmaceutical composition for treating inflammation
#530Methods and Compositions for Treating Tumors
#531Dna Delivery with Gemini Cationic Surfactants
#532COMPOSITIONS AND METHODS FOR TREATING DISEASES THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE
#533Marketing System for Improving Patient Compliance and Methods and Devices Relating to Same
#534Compositions Containing Agm Cells And Methods Of Use Thereof
#535Therapeutic compositions and methods useful in treating cancer
#536Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture
#537Methods of treating idiopathic pulmonary fibrosis
#538Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine
#539Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
#540Method of promoting the healing of a chronic wound
#541Compositions capable of facilitating penetration across a biological barrier
#542METHODS, PHARMACEUTICAL FORMULATIONS AND KITS FOR IDENTIFICATION OF SUBJECTS AT RISK FOR CANCER
#543Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
#544Combination therapy for anthrax using antibiotics and protease inhibitors
#545ANTIBODY THERAPY
#546METHOD TO ENHANCE HEMATOPOIESIS
#547Compositions capable of facilitation penetration across a biological barrier
#548Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
#549METHOD FOR MODULATING HLA CLASS II TUMOR CELL SURFACE EXPRESSION WITH A CYTOKINE MIXTURE
#550Interferon gamma therapies for idiopathic pulmonary fibrosis
#551Compositions and methods for treating poxvirus infection
#552Use of pirfenidone in therapeutic regimens
#553Hox11+, CD45− cells and methods of organ regeneration using the same
#554Medicinal composition for treatment of chronic hepatitis c
#555Methods of treating idiopathic pulmonary fibrosis
#556Macrocyclic inhibitors of hepatitis C virus replication
#557Methods of treating idiopathic pulmonary fibrosis
#558Vaccine immunotherapy for immune suppressed patients
#559Combination therapy for cancer treatment
#560In vivo targeting of dendritic cells
#561Vaccine immunotherapy
#562Adenoviral vectors for treating diseases
#563Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
#564Adenoviral vectors for treating diseases
#565Adenoviral vectors for treating diseases
#566Method for modulating HLA class II tumor cell surface expression with a cytokine mixture
#567Targeted vectors for cancer immunotherapy
#568Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers
#569Methods of treating or preventing a disease, disorder or condition associated with a viral infection
#570Compositions and methods for treating viral infections
#571Immunotherapy for immune suppressed patients
#572Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
#573Genetically modified tumor cells as cancer vaccines
#574Method for administering a cytokine to the central nervous system and the lymphatic system
#575Formulations useful against hepatitis C virus infections
#576Method and composition for regulating the activity of regulatory t cells
#577Combination gene delivery vehicles
#578Combination therapy for treatment of fibrotic disorders
#579Dose forms
#580Remedy for pemphigoid
#5813,3'-Diindolylmethane immune activating compositions
#582B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#583Therapeutic agent for hematopoietic tumors
#584Freeze-dried interferon-y composition for transpulmonary administration and inhalation system therefor
#585Methods of treating ocular inflammation and allergy
#586Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds
#587Interferon compositions and methods of use thereof
#588Drug discovery method
#589Cancer - targeted viral vectors
#590Nanogene therapy for cell proliferation disorders
#591Packaging cells
#592Compositions and methods for treatment of ulcerative colitis
#593Method and composition for regulating activity of regulatory T cells
#594Treatment of inflammatory bowel disease
#595Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
#596Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma
#597Uses of interferons with altered spatial structure
#598Method for delivering therapeutic proteins to the intradermal compartment
#599Methods of treating NFAT-related disorders
#600Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase